Abiding by the old rules and waiting for a severely preeclamptic patient's diastolic blood pressure (BP) to reach or rise above 110 mm Hg before beginning to treat hypertension can invite a deadly stroke, warned a leading Jackson, Miss. maternal-fetal medicine researcher. Instead, consider treating as a hypertensive emergency a pregnant patient's sudden severe systolic BP reading of 155 to 160 mm Hg or more, regardless of the diastolic reading, said James N. Martin, Jr., MD, Professor of Obstetrics and Gynecology, and Director of Maternal-Fetal Medicine and Obstetrics at the University of Mississippi School of Medicine.
Abiding by the old rules and waiting for a severely preeclamptic patient's diastolic blood pressure (BP) to reach or rise above 110 mm Hg before beginning to treat hypertension can invite a deadly stroke, warned a leading Jackson, Miss. maternal-fetal medicine researcher. Instead, consider treating as a hypertensive emergency a pregnant patient's sudden severe systolic BP reading of 155 to 160 mm Hg or more, regardless of the diastolic reading, said James N. Martin, Jr., MD, Professor of Obstetrics and Gynecology, and Director of Maternal-Fetal Medicine and Obstetrics at the University of Mississippi School of Medicine.
In speaking on "Aggressive Management of HELLP Syndrome" (hemolysis, elevated liver enzymes, and low platelet count at the ACOG District II/NY Annual Meeting in New York City, Dr. Martin reiterated his call for a paradigm shift focusing on systolic rather than conventional BPs in women with severe preeclampsia and eclampsia-based on his group's data published earlier this year (Obstet Gynecol. 2005;105:246-256). In contrast, the conventional general recommendation of the American College of Obstetricians and Gynecologists in its most recent practice bulletin (Diagnosis and Management of Preeclampsia and Eclampsia. No. 33, January 2002) is to begin antihypertensive therapy when diastolic BP levels reach 105 to 110 mm and higher.
"This should serve as a wake-up call that an observational study of thousands of women is still needed," Dr. Martin said of his group's earlier findings from a small study of 28 women. The study found that for the pregnant adult who develops acute severe hypertension-especially if she has severe preeclampsia/eclampsia-there seems to be a closer correlation with systolic than diastolic hypertension for risk of hemorrhagic stroke. (Diastolic BP can still be a factor, but a lesser one.)
HELLP syndrome calls for aggressive treatment like BP control and the well-known dexamethasone "rescue therapy" pioneered by Dr. Martin's tertiary care center at UMC, he said, because it's a complex disease process "that has its genesis at the beginning of the pregnancy, but we see it only in the ninth inning."
Martin JN. Aggressive Management of HELLP Syndrome. Presented at ACOG District II/NY Annual Meeting, October 28-30, 2005.
Unlocking HPV prevention: Insights from 2022 data on vaccination trends
May 14th 2024Explore the latest findings revealing vaccination rates among children aged 9 to 17 years, uncovering demographic disparities and highlighting the crucial role of vaccination in combating human papillomavirus infections and related health risks.
Read More
Prenatal cannabis and nicotine use linked to adverse pregnancy outcomes
May 14th 2024A recent study highlights the heightened risks of maternal and neonatal morbidity and mortality associated with combined cannabis and nicotine use during pregnancy, urging further investigation into their impact on short- and long-term outcomes.
Read More
Understanding pediatric STIs: Trends, management, and more
May 10th 2024Dive into the rising prevalence of sexually transmitted infections among adolescents and young adults, exploring educational gaps, vaccination rates, and the imperative need for open conversations between patients and health care providers to combat stigma and enhance preventive care.
Read More
No link found between antenatal corticosteroids and child neurodevelopment
April 25th 2024A recent study found no link between antenatal corticosteroid administration and adverse neurodevelopmental outcomes in children aged 6 years or older, offering reassurance for late preterm delivery practices.
Read More